Axiom Investors LLC Paratek Pharmaceuticals, Inc. Transaction History

Axiom Investors LLC

  • $11.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Feb 14, 2018
SELL
$17.45 - $25.6 $868,172 - $1.27 Million
-49,752 Closed
0 $0
Q3 2017

Nov 09, 2017
SELL
$18.9 - $28.2 $267,057 - $398,466
-14,130 Reduced 22.12%
49,752 $1.25 Million
Q2 2017

Aug 14, 2017
BUY
N/A
63,882
63,882 $1.54 Million

Others Institutions Holding PRTK

# of Institutions
4
Shares Held
1.54M
Call Options Held
0
Put Options Held
0
View Full List

About Paratek Pharmaceuticals, Inc.

PRTK Quotes by TradingView
  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Axiom Investors LLC Portfolio

Follow Axiom Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axiom Investors LLC , based on Form 13F filings with the SEC.

News

Stay updated on Axiom Investors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email